Functional characterization of the hexose transporter Hxt13p: An efflux pump that mediates resistance to miltefosine in yeast

被引:11
作者
Biswas, Chayanika [1 ]
Djordjevic, Julianne T. [1 ]
Zuo, Xiaoming [1 ]
Boles, Eckhard [4 ]
Jolliffe, Katrina A. [3 ]
Sorrell, Tania C. [1 ,2 ]
Chen, Sharon C. -A. [1 ,2 ]
机构
[1] Westmead Millennium Inst, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia
[2] Univ Sydney, Sydney Emerging Infect & Biosecur Inst, Sydney, NSW 2145, Australia
[3] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[4] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany
基金
英国医学研究理事会;
关键词
Miltefosine; Hexose transporter; HXT13; Overexpression; Resistance; Efflux pump; DRUG-RESISTANCE; MITOCHONDRIAL GENOME; ANTIFUNGAL AGENTS; MECHANISMS; LEISHMANIA; HEXADECYLPHOSPHOCHOLINE; MAINTENANCE; PANEL;
D O I
10.1016/j.fgb.2013.09.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Miltefosine (MI) has in vitro fungicidal activity against pathogenic fungi. However, mechanisms of resistance to MI have not been studied. By screening a genomic library of the model yeast, Saccharomyces cerevisiae, we identified HXT13 as a candidate genetic determinant of MI resistance. HXT13 belongs to the yeast hexose transporter family, which mediates hexose sugar uptake and is included in the major facilitator superfamily (MFS). We now report that overexpression of HXT13, but not of the closely-related genes, HXT15 and HXT17, and the more distantly related HXT14, resulted in a stable MI-resistant phenotype in S. cerevisiae. Resistance of the HXT13 overexpressing strain to MI correlated with higher cell viability following MI exposure as assessed by SYTOX (R) green staining compared with the control and overexpressing HXT14 strains. The mechanism of resistance in the HXT13 overexpressing strain was due to increased ATP-independent MI efflux. However, resistance to MI of the HXT13-overexpressing strain did not extend to other drugs including the echinocandins, amphotericin B, azoles, cycloheximide and sulfometuron methyl, ruling out the involvement of HXT13 in multidrug resistance. In summary, we have identified a new function of the hexose sugar transporter gene HXT13 when overexpressed in S. cerevisiae, namely, in efflux of MI and in mediating MI resistance. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 39 条
[21]   Intestinal absorption of miltefosine:: Contribution of passive paracellular transport [J].
Menez, Cecile ;
Buyse, Marion ;
Dugave, Christophe ;
Farinotti, Robert ;
Barratt, Gillian .
PHARMACEUTICAL RESEARCH, 2007, 24 (03) :546-554
[22]   Functional expression of candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters [J].
Nakamura, K ;
Niimi, M ;
Niimi, K ;
Holmes, AR ;
Yates, JE ;
Decottignies, A ;
Monk, BC ;
Goffeau, A ;
Cannon, RD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3366-3374
[23]   Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: Involvement of two hexose transporters [J].
Nourani, A ;
WesolowskiLouvel, M ;
Delaveau, T ;
Jacq, C ;
Delahodde, A .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5453-5460
[24]   Survival Strategies of Yeast and Filamentous Fungi against the Antifungal Protein AFP [J].
Ouedraogo, Jean Paul ;
Hagen, Silke ;
Spielvogel, Anja ;
Engelhardt, Susanne ;
Meyer, Vera .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (16) :13859-13868
[25]   Membrane homoeostasis and multidrug resistance in yeast [J].
Panwar, Sneh Lata ;
Pasrija, Ritu ;
Prasad, Rajendra .
BIOSCIENCE REPORTS, 2008, 28 (04) :217-228
[26]  
Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1
[27]   Mechanisms of experimental resistance of Leishmania to miltefosine:: Implications for clinical use [J].
Perez-Victoria, F. Javier ;
Sanchez-Canete, Maria P. ;
Seifert, Karin ;
Croft, Simon L. ;
Sundar, Shyam ;
Castanys, Santiago ;
Gamarro, Francisco .
DRUG RESISTANCE UPDATES, 2006, 9 (1-2) :26-39
[28]   Functional cloning of the miltefosine transporter -: A novel P-type phospholipid translocase from Leishmania involved in drug resistance [J].
Pérez-Victoria, FJ ;
Gamarro, F ;
Ouellette, M ;
Castanys, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :49965-49971
[29]   Antifungal drug resistance: do molecular methods provide a way forward? [J].
Perlin, David S. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (06) :568-573
[30]  
Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257